← FDA Drug Approvals (Drugs@FDA)

NEXLIZET

NDA · New Drug Application · Sponsor: ESPERION THERAPS INC · Approved 2020-02-26

Drug application

FDA Application #

NDA211617

Application type

New Drug Application

Brand name

NEXLIZET

Generic name

BEMPEDOIC ACID AND EZETIMIBE

Active ingredients

BEMPEDOIC ACID; EZETIMIBE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ESPERION THERAPS INC

Manufacturer

Esperion Therapeutics, Inc.

First approval

2020-02-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown